The role of FDG-PET in the interim evaluation of therapy response in diffuse large B-cell lymphoma

被引：0
|
作者：
Ellmann, Annare [1 ,2 ]
机构：
[1] Univ Stellenbosch, Cape Town, South Africa
[2] Tygerberg Hosp, Cape Town, South Africa
来源：
TRANSFUSION AND APHERESIS SCIENCE | 2013年 / 49卷 / 01期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; INTERNATIONAL HARMONIZATION PROJECT; SUV-BASED ASSESSMENT; PROGNOSTIC VALUE; F-18-FDG PET; MALIGNANT-LYMPHOMA; CHEMOTHERAPY; SCANS; FLUORODEOXYGLUCOSE;
D O I：
10.1016/j.transci.2013.05.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The significance of FDG PET in the interim follow-up of patients with diffuse large B-cell lymphoma to evaluate therapy response is currently being debated. Reports with discordant results have been published. Several authors have reported a low positive predictive value when using FDG PET to evaluate interim therapy response. Different criteria for the interpretation of PET studies in these patients are available, producing variable results. The latest publications and the review criteria will be summarised in this paper. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：40 / 42
页数：3
相关论文
共 50 条
  • [1] An Update on the Role of Interim Restaging FDG-PET in Patients With Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
    Moskowitz, Craig H.
    Zelenetz, Andrew
    Schoder, Heiko
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (03): : 347 - 352
  • [2] Interim PET in Diffuse Large B-Cell Lymphoma
    Kurch, Lars
    Huettmann, Andreas
    Georgi, Thomas W.
    Rekowski, Jan
    Sabri, Osama
    Schmitz, Christine
    Kluge, Regine
    Duehrsen, Ulrich
    Hasenclever, Dirk
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 1068 - 1074
  • [3] Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
    Fuertes, Silvia
    Setoain, Xavier
    Lopez-Guillermo, Armando
    Carrasco, Josep-Lluis
    Rodriguez, Sonia
    Rovira, Jordina
    Pons, Francesca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 496 - 504
  • [4] The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma
    Hoppe, B. S.
    Moskowitz, C. H.
    Zhang, Z.
    Maragulia, J. C.
    Rice, R. D.
    Reiner, A. S.
    Hamlin, P. A.
    Zelenetz, A. D.
    Yahalom, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 (12) : 941 - 948
  • [5] FDG-PET for Early Response Assessment in Lymphomas PART 2: Diffuse Large B-Cell Lymphoma, Use of Quantitative PET Evaluation
    Cheson, Bruce D.
    Kostakoglu, Lale
    ONCOLOGY-NEW YORK, 2017, 31 (01): : 71 - 76
  • [6] FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcome
    Han, Eun Ji
    O, Joo Hyun
    Yoon, Hyukjin
    Jung, Seung Eun
    Park, Gyeongsin
    Choi, Byung Ock
    Cho, Seok-Goo
    MEDICINE, 2016, 95 (39)
  • [7] Role of early PET in the management of diffuse large B-cell lymphoma
    Michallet, Anne-Sophie
    Trotman, Judith
    Tychyj-Pinel, Christelle
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (05) : 414 - 418
  • [8] Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphoma
    Wight, Joel
    Wai, Shin Hnin
    Shen, Edward
    Lee, Sze-Ting
    Berlangieri, Salvatore
    Fancourt, Tineke
    Hawkes, Eliza
    Hannah, Anthony
    Leung, Teresa
    Chong, Geoffrey
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (04) : 475 - 483
  • [9] Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma
    Lazarovici, Julien
    Terroir, Marie
    Arfi-Rouche, Julia
    Michot, Jean-Marie
    Mussot, Sacha
    Florea, Valentina
    Ghigna, Maria-Rosa
    Dartigues, Peggy
    Petrovanu, Cynthia
    Danu, Alina
    Ferme, Christophe
    Ribrag, Vincent
    Ghez, David
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) : 2018 - 2024
  • [10] Variability of hepatic 18-FDG uptake at interim PET/CT in diffuse large B-cell lymphomas
    Gordien, P.
    Morliere, C.
    Bordenave, L.
    Hindie, E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2014, 38 (02): : 83 - 90
12345